As of May 27, 2025, Vericel Corp (VCEL) reports a ROA (Return on Assets) of 2.39%.
ROA (Return on Assets) evaluates how effectively a company turns its assets into profits, showcasing resource utilization.
Historical Trend of Vericel Corp's ROA (Return on Assets)
Over recent years, Vericel Corp's ROA (Return on Assets) has shown a stable trend. The table below summarizes the historical values:
| Date | ROA (Return on Assets) |
|---|---|
| 2024-12-31 | 2.39% |
| 2023-12-31 | -0.90% |
| 2022-12-31 | -6.12% |
| 2021-12-31 | -3.08% |
| 2020-12-31 | 1.41% |
This steady improvement highlights how Vericel Corp manages its efficiency in using assets to generate earnings over time.
Comparing Vericel Corp's ROA (Return on Assets) to Peers
To better understand Vericel Corp's position, it's useful to compare its ROA (Return on Assets) against industry peers. Below are selected comparisons:
| Company | ROA (Return on Assets) |
|---|---|
| Vericel Corp (VCEL) | 2.39% |
| Agios Pharmaceuticals Inc (AGIO) | 40.51% |
| MiMedx Group Inc (MDXG) | 16.07% |
| Regeneron Pharmaceuticals Inc (REGN) | 11.69% |
| MannKind Corp (MNKD) | 7.00% |
| Amgen Inc (AMGN) | 4.45% |
Compared to its competitors, Vericel Corp's ROA (Return on Assets) is among the highest compared to peers, demonstrating superior efficiency in generating earnings from assets.